← Leaderboards
Heidi V Russell
Baylor College Of Medicine
$54,646
Attributed
$54,646
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.8K · FY2006–09$20K$15K$10K$5K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$54,646 · 9
By mechanism
M01$54,646 · 9
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Helen E Heslop$25,308,937
- Cliona M Rooney$13,445,584
- Susan M Blaney$10,519,074
- David G. Poplack$17,817,283
- Stephen Gottschalk$13,145,706
Others in their field
Top investigators on “Neuroblastoma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gregory H Reaman · National Childhood Cancer Foundation$84,462,747
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$58,436,699
- Larry Arthur$30,516,306
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
NeuroblastomaResearch PersonnelGrantSourceComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionResourcesDoseFundingUnited States National Institutes Of HealthOralDrug KineticsScheduleRecurrenceToxic EffectClinical TrialsClinical ResearchChildT-LymphocyteRefractoryBone ResorptionClinical Trials, Phase IGrowth FactorMaximum Tolerated Dose
Grant awards (9)
CLINICAL TRIAL: A PHASE I STUDY OF ZOLEDRONIC ACID (ZOMETA) WITH CYCLOPHOSPHAMID$1,185
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: NANT 2004-04: PHASE I STUDY OF FENRETINIDE (4-HPR, NSC 374551)$593
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE I STUDY OF ZOLEDRONIC ACID (ZOMETA) WITH CYCLOPHOSPHAMID$5,354
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: NANT 2004-04: PHASE I STUDY OF FENRETINIDE (4-HPR, NSC 374551)$1,561
M01 · FY2008 · RR · contact PI
A PHASE I STUDY OF ZOLEDRONIC ACID (ZOMETA) WITH CYCLOPHOSPHAMIDE IN CHILDREN$9,080
M01 · FY2007 · RR · contact PI
ADMINISTRATION OF PERIPHERAL BLOOD T-CELLS AND EBV SPECIFIC CTLS TRANSDUCED TO$4,686
M01 · FY2007 · RR · contact PI
ADMINISTRATION OF PERIPHERAL BLOOD T-CELLS AND EBV SPECIFIC CTLS$6,204
M01 · FY2006 · RR · contact PI
Gene Modified Autologous Neuroblastoma Vaccine for Remission Neuroblastoma$25,131
M01 · FY2004 · RR
Pilot Study of 1A7 Antibody as Vaccine for Patients with Advanced Neuroblastoma$852
M01 · FY2004 · RR